文献速递系统性红斑狼疮

系统性红斑狼疮血清学聚类及其临床与预后意义:纵向队列研究

Serological clusters in systemic lupus erythematosus and its clinical and prognostic implications: A longitudinal cohort study.
PubMed 文献 · Semin Arthritis Rheum · 2025-08-28

该研究基于西班牙RELESSER注册中心的多中心观察性研究,纳入横断面阶段1740例和前瞻性阶段718例(随访4年)SLE患者,采用Gower距离进行聚类分析,识别出4个血清学聚类。聚类2(抗磷脂抗体阳性)基线SLICC/ACR DI损伤评分更高,聚类4(抗Sm和抗核糖核蛋白抗体阳性)Katz指数严重度评分更高,且这些差异持续4年随访。结论认为血清学特征对临床分层和预后判断具有重要价值。

要点

  • 基于Gower距离聚类分析识别出4个SLE血清学聚类:ENA阴性、抗磷脂抗体阳性、抗SSA/SSB阳性、抗Sm/RNP阳性。
  • 聚类4(抗Sm/RNP阳性)狼疮肾炎、白细胞减少、淋巴细胞减少、低补体血症、肌炎及皮肤表现发生率更高,糖皮质激素和免疫抑制剂使用更多。
  • 聚类2(抗磷脂抗体阳性)基线SLICC/ACR DI损伤评分更高,聚类4的Katz指数严重度评分更高,差异持续4年随访。

核心结论

  • 在西班牙RELESSER注册中心的SLE患者人群中,血清学特征不仅对临床分层具有关键作用,还具有预后价值。

研究设计与样本

  • 描述性、观察性、多中心研究,纳入西班牙RELESSER注册中心的SLE患者,采用Gower距离进行聚类分析。
  • 横断面阶段纳入1740例患者,前瞻性阶段纳入718例患者并随访4年。

主要发现

  • 识别出4个血清学聚类:聚类1为可提取核抗原(ENA)阴性,血管炎、白细胞减少和淋巴细胞减少频率较低。
  • 聚类2为抗磷脂抗体阳性,更常出现溶血性贫血、血小板减少、血管炎和视觉异常,免疫球蛋白和口服抗凝药使用更多。
  • 聚类3为抗SSA/Ro和抗SSB/La阳性,狼疮肾炎发生率较低。
  • 聚类4为抗Sm和抗核糖核蛋白抗体阳性,狼疮肾炎、白细胞减少、淋巴细胞减少、低补体血症、肌炎和皮肤表现发生率更高,糖皮质激素和免疫抑制剂使用更多。
  • 聚类2患者基线SLICC/ACR DI损伤评分更高,聚类4患者Katz指数严重度评分更高,这些聚类间差异持续4年随访。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Systemic lupus erythematosus (SLE) is a heterogeneous autoimmune disorder characterized by multi-organ involvement and variable clinical manifestations. Recurrent clinical patterns suggest distinct phenotypes, where cluster analysis of autoantibodies could identify prognostic subtypes. OBJECTIVES: To define and describe serological clusters and their clinical-epidemiological characteristics, as well as their association with comorbidities, disease activity measures, severity, and damage. MATERIALS AND METHODS: Descriptive, observational, and multicenter study including SLE patients from the Spanish Registry RELESSER. Gower distance was used for cluster analysis. RESULTS: A total of 1,740 patients from the cross-sectional phase and 718 from the prospective phase with a four-year follow-up were included. Four serological clusters were identified. Cluster 1 (negative for extractable nuclear antigen [ENA]) was characterized by a lower frequency of vasculitis, leukopenia, and lymphopenia. Cluster 2 (positive antiphospholipid antibodies) more frequently presented haemolytic anaemia, thrombocytopenia, vasculitis and visual alterations and required greater use of immunoglobulins and oral anticoagulants. Cluster 3 (positive anti-SSA/Ro and anti-SSB/La) had a lower incidence of lupus nephritis. Cluster 4 (positive anti-Sm and anti-ribonucleoproteins) was characterized by higher rates of lupus nephritis, leukopenia, lymphopenia, hypocomplementemia, myositis and cutaneous manifestations and greater use of glucocorticoids and immunosuppressants. Patients in cluster 2 had higher baseline damage scores measured by the SLICC/ACR DI (Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index), while patients in cluster 4 had higher severity scores measured by the Katz Index. These differences among clusters persisted over the four-year of follow-up. CONCLUSION: In our SLE patient population, the serological profile is key not only for clinical stratification but also for prognostic value.

来源:Semin Arthritis Rheum,查看原文。版权归原作者所有。

引用

  1. Ibarguengoitia-Barrena O, Riancho-Zarrabeitia L, Plaza Z, et al. Serological clusters in systemic lupus erythematosus and its clinical and prognostic implications: A longitudinal cohort study. Semin Arthritis Rheum. 2025. PMID: 40911945. doi:10.1016/j.semarthrit.2025.152819

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。